ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
0.00%
Bitcoin
68,092.59
0.54%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. RayzeBio Inc (RYZB)

  7. RayzeBio Inc (RYZB) News

RYZB

RayzeBio (RYZB)

RayzeBio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RYZB
DateTimeSourceHeadlineSymbolCompany
03/07/20243:07PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:RYZBRayzeBio Inc
02/27/20243:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYZBRayzeBio Inc
02/27/20243:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYZBRayzeBio Inc
02/26/20248:20AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RYZBRayzeBio Inc
02/26/20248:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYZBRayzeBio Inc
02/23/20246:53AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RYZBRayzeBio Inc
02/23/20245:59AMBusiness WireBristol Myers Squibb Announces Expiration of RayzeBio Tender OfferNASDAQ:RYZBRayzeBio Inc
02/14/20248:19AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RYZBRayzeBio Inc
02/12/20247:54AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RYZBRayzeBio Inc
02/12/20245:59AMBusiness WireBristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting PeriodNASDAQ:RYZBRayzeBio Inc
02/06/20245:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYZBRayzeBio Inc
01/25/20247:53AMEdgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:RYZBRayzeBio Inc
01/08/20249:06AMPR Newswire (US)Kuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to Contact Law FirmNASDAQ:RYZBRayzeBio Inc
12/27/20233:15PMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:RYZBRayzeBio Inc
12/26/20234:08PMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:RYZBRayzeBio Inc
12/26/20239:28AMDow Jones NewsTrending: Bristol Myers Squibb to Buy RayzeBioNASDAQ:RYZBRayzeBio Inc
12/26/20237:32AMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:RYZBRayzeBio Inc
12/26/20237:26AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYZBRayzeBio Inc
12/26/20237:04AMDow Jones NewsRayzeBio Shares Soar Premarket on Takeover by Bristol MyersNASDAQ:RYZBRayzeBio Inc
12/26/20236:46AMDow Jones NewsBristol Myers Squibb to Buy RayzeBio for $4.1 BillionNASDAQ:RYZBRayzeBio Inc
12/26/20236:13AMGlobeNewswire Inc.Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBioNASDAQ:RYZBRayzeBio Inc
12/26/20235:59AMBusiness Wire Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBioNASDAQ:RYZBRayzeBio Inc
11/17/20235:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYZBRayzeBio Inc
11/17/20235:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYZBRayzeBio Inc
11/13/20233:04PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RYZBRayzeBio Inc
11/13/20233:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYZBRayzeBio Inc
11/13/20233:01PMGlobeNewswire Inc.RayzeBio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:RYZBRayzeBio Inc
11/06/20233:05PMGlobeNewswire Inc.RayzeBio to Participate in Upcoming Investor Conferences in November 2023NASDAQ:RYZBRayzeBio Inc
11/01/20238:14AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYZBRayzeBio Inc
11/01/20235:00AMGlobeNewswire Inc.RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of DirectorsNASDAQ:RYZBRayzeBio Inc
 Showing the most relevant articles for your search:NASDAQ:RYZB

Your Recent History

BIT
P19KE4
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved